Single-Cell Genomics and Proteomics: Emerging Technologies and Markets
商品番号 : SMB-76061
| 出版社 | BCC Research |
| 出版年月 | 2025年4月 |
| ページ数 | 129 |
| 図表数 | 148 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,650 |
| 種別 | 英文調査報告書 |
シングルセルゲノミクスとプロテオミクスの新興技術と世界市場は2024年から2029年にかけて年平均成長率（CAGR）17.6%で成長し、2024年の40億ドルから2029年末までに91億ドルに達するとBCC Researchでは予測しています。
当レポートでは現在および今後のシングルセルゲノミクスとプロテオミクス市場を対象に分析を行い、主要セグメント別に分析・予測を行っています。また主要プレイヤーの企業情報も提供します。
調査対象セグメント
- 解析タイプ
- シングルセルゲノミクス
- シングルセルプロテオミクス
- シングルセルトランスクリプトミクス
- シングルセルエピゲノミクス
- 用途
- 腫瘍学
- 幹細胞生物学
- 免疫学
- その他の用途
- エンドユーザ
- 学術機関および研究機関
- バイオ医薬品企業およびバイオテクノロジー企業
- 臨床検査室
- 地域
- 北米
- 欧州
- アジア太平洋地域
- その他の地域（RoW）
調査対象企業
- 10X GENOMICS
- AGILENT TECHNOLOGIES INC.
- BD
- BIO-RAD LABORATORIES INC.
- BIO-TECHNE
- BRUKER
- F. HOFFMANN-LA ROCHE LTD.
- ILLUMINA INC.
- MERCK KGAA
- PROMEGA CORP.
- QIAGEN
- SARTORIUS AG
- STANDARD BIOTOOLS
- TECAN TRADING AG
- THERMO FISHER SCIENTIFIC INC.
主な掲載内容
- エグゼクティブサマリー
- 市場概観
- マクロ経済要因分析
- ファイブフォース分析
- 規制環境
- 規制概要
- 国／地域別市場規制
- 国際規格とガイドライン
- 市場力学
- 市場成長促進要因
- 市場成長阻害要因
- 市場機会
- 新興技術と開発
- シングルセルゲノミクスおよびプロテオミクスにおける人工知能
- シングルセルオミクスおよびマルチオミクスの進歩
- セグメント別市場分析
- 解析タイプ
- シングルセルゲノミクス
- シングルセルプロテオミクス
- シングルセルトランスクリプトミクス
- シングルセルエピゲノミクス
- 用途
- 腫瘍学
- 幹細胞生物学
- 免疫学
- その他の用途
- エンドユーザ
- 学術機関および研究機関
- バイオ医薬品企業およびバイオテクノロジー企業
- 臨床検査室
- 地域
- 北米
- 欧州
- アジア太平洋地域
- その他の地域（RoW）
- 解析タイプ
- 競合情報
- ESG視点からのゲノミクスおよびプロテオミクス市場における持続可能性
- 付録
- メソドロジー
- 略語一覧
- 企業情報
Report Highlights
The global market for single-cell genomics and proteomics is expected to grow from $4.0 billion in 2024 to reach $9.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 17.6% from 2024 through 2029.
Summary
The demand for single-cell genomics and proteomics is rapidly increasing across global research and healthcare markets, driven by advances in single-cell analysis technologies and their ability to provide unprecedented insights into cellular heterogeneity. With the rising focus on personalized medicine, oncology and immune profiling, single-cell technologies are becoming indispensable tools for identifying biomarkers, understanding disease mechanisms and developing targeted therapies.
The growing prevalence of chronic and complex diseases, such as cancer, neurodegenerative disorders and autoimmune diseases, has highlighted the importance of single-cell approaches in precision medicine. These technologies enable researchers to study individual cells at genomic and proteomic levels, uncovering critical information that bulk analysis often misses. The significant investments in single-cell research, coupled with ongoing technological innovations in sequencing, mass spectrometry and data analysis platforms, are fueling the adoption of single-cell genomics and proteomics. Increasing collaborations between academic institutions, biotech companies, and healthcare providers are further accelerating the development and commercialization of single-cell technologies. Comprehensive market sizing and forecasting will enable stakeholders to identify high-growth segments and regions, understand competitive dynamics and make informed decisions for strategic planning during the forecast period.
Report Synopsis
| Report Metrics | Details | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2023 | ||||||||||||||||
| Forecast period considered | 2024-2029 | ||||||||||||||||
| Base year market size | $3.4 Billion | ||||||||||||||||
| Market size forecast | $9.1 Billion | ||||||||||||||||
| Growth rate | CAGR of 17.6% from 2024 to 2029 | ||||||||||||||||
| Units considered | $ Millions | ||||||||||||||||
| Segments covered | By Analysis Type, Application, End User, and Region | ||||||||||||||||
| Regions covered | North America, Europe, Asia-Pacific and the Rest of the World (RoW) | ||||||||||||||||
| Key Market Drivers |
| ||||||||||||||||
| Companies studied |
| ||||||||||||||||
Report Scope:
The report highlights the current and future market potential of single-cell genomics and proteomics and a detailed analysis of the market drivers, restraints and opportunities. The report also covers market projections for 2029, including a competitive environment and product analysis. The report provides market estimates and forecasts for single-cell genomics and proteomics based on analysis type, application, end user and region. Based on product type, the market is segmented into single-cell genomics, single-cell epigenomics and single-cell transcriptomics. The market is categorized as academic and research organizations, biopharmaceutical and biotechnology companies, and applied markets and clinical laboratories based on end user. The market is segmented into stem cell biology, oncology, immunology, microbiology and others based on application.
The report includes the company profiles of the key players with detailed information about their business segments, financials, product portfolios and recent developments. By geography, the market has been organized into North America, Europe, Asia-Pacific and the Rest of the World (RoW). The North American region includes countries such as the U.S., Canada and Mexico. Europe includes Germany, the UK, Italy, France, Spain and the rest of Europe; Asia-Pacific includes countries such as China, Japan, India, Australia, South Korea and the rest of Asia-Pacific. The Rest of the World includes South America and the Middle East and Africa. For market estimates, data has been provided for 2021 and 2022 as the historic years, 2023 as the base year, and forecast for 2029.
Report Includes:
– 43 data tables and 59 additional tables
– An overview of the global markets and emerging technologies for single-cell genomics and proteomics
– Analyses of the global market trends, with data from 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
– Evaluation of and forecast for the overall market for single-cell genomics and proteomics, and quantification of the market potential by analysis type, application, end user and region
– Description of cell isolation technologies, including flow cytometry, laser capture microscopy and micromanipulation, and sample preparation technologies, including microfluidics and whole genome amplification/pre-amplification
– Coverage of NGS, qPCR/PCR, microarrays, mass spectrometry and microfluidics
– Discussion of the major market dynamics and shifts, and the regulations, industry challenges, and macroeconomic factors that will affect the single-cell genomics and proteomics market over the coming years
– Review of the patent filings and research publications for innovations in single-cell genomics and proteomics technology
– A discussion of the industry’s ESG challenges and practices
– Identification of the companies that are best positioned to meet this demand because of their proprietary technologies, strategic alliances, or other advantages
– Insight into industry structure, competitive landscape, clinical trials and ongoing research activity
– Profiles of the major players, including 10x Genomics, Thermo Fisher Scientific Inc., Illumina Inc., BD and Merck KGaA
Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Chapter 2 Market Overview
Overview
Technology Background
Types of Omics
Technological Infrastructure and Data Integration
Macroeconomic Factors Analysis
Impact of Ongoing Russia-Ukraine War on the Single-cell Genomics and Proteomics Market
Economic Uncertainty and Research Funding Cuts
Increased Operational Costs
Shift in Geopolitical Collaborations
Sanctions on Russia and Technology Exports
Porter’s Five Forces Analysis
Bargaining Power of Buyers
Bargaining Power of Suppliers
Potential of New Entrants
Competition in the Industry
Threat of Substitutes
Chapter 3 Regulatory Landscape
Regulatory Overview
Market Regulations by Country/Region
Federal Regulation
CMS Regulation
FDA Regulation
FTC Regulation
Canada
European Union
United Kingdom (U.K.)
China
Japan
Australia
International Standards and Guidelines
Chapter 4 Market Dynamics
Market Dynamics
Market Drivers
Increasing Investment and Funding for Single-cell Genomics and Proteomics Research Activities
Growing Prevalence of Cancer Generating Demand for Personalized Treatments
Promising Applications of Single-cell Genomics and Proteomics in the Drug Development Process
Market Restraints
High Costs Associated with Single-cell Proteomics
Technical Challenges
Market Opportunities
Technological Advances and Automation in Single-cell Studies
Collaboration and Partnerships
Chapter 5 Emerging Technologies and Developments
Artificial Intelligence in Single-cell Genomics and Proteomics
Companies in the AI Single-cell Genomics and Proteomics Market
Advances in Single-cell Omics and Multi-omics
Chapter 6 Market Segmentation Analysis
Market Overview
Segmentation Breakdown
Global Single-cell Genomics and Proteomics Market by Analysis Type
Single-cell Genomics
Single-cell Proteomics
Single-cell Transcriptomics
Single-cell Epigenomics
Global Single-cell Genomics and Proteomics Market by Application
Oncology
Stem Cell Biology
Immunology
Other Applications
Global Single-cell Genomics and Proteomics Market by End User
Academic and Research Organizations
Biopharmaceutical and Biotechnology Companies
Clinical Laboratories
Applied Markets
Geographic Breakdown
Global Single-cell Genomics and Proteomics Market by Region
North America
Europe
Asia-Pacific
Rest of the World
Chapter 7 Competitive Intelligence
Overview
Top Players Ranking
Key Strategies Adopted by Players
Collaborations and Partnerships
New Product Launches
Expansions and Investments
Mergers and Acquisitions
Patent Analysis
Takeaways
Chapter 8 Sustainability in the Genomics and Proteomics Market: ESG Perspective
Introduction to ESG
ESG Performance in the Market
ESG Practices in the Genomics and Proteomics Industry
Environmental Performance
Social Performance
Governance Performance
ESG Risk Ratings
Concluding Remarks from BCC Research
Chapter 9 Appendix
Methodology
Abbreviations
Company Profiles
10X GENOMICS
AGILENT TECHNOLOGIES INC.
BD
BIO-RAD LABORATORIES INC.
BIO-TECHNE
BRUKER
HOFFMANN-LA ROCHE LTD.
ILLUMINA INC.
MERCK KGAA
PROMEGA CORP.
QIAGEN
SARTORIUS AG
STANDARD BIOTOOLS
TECAN TRADING AG
THERMO FISHER SCIENTIFIC INC.
List of Tables
Summary Table : Global Single-cell Genomics and Proteomics Market, by Region, Through 2029
Table 1 : Molecular Biology Technologies for Multi-omics Approaches
Table 2 : Single-cell and Spatial Omics Technologies, 2018–2023
Table 3 : Companies in the AI Single-cell Genomics and Proteomics Market
Table 4 : Global Single-cell Genomics and Proteomics Market, by Analysis Type, Through 2029
Table 5 : Global Single-cell Genomics Market, by Region, Through 2029
Table 6 : Global Single-cell Proteomics Market, by Region, Through 2029
Table 7 : Global Single-cell Transcriptomics Market, by Region, Through 2029
Table 8 : Global Single-cell Epigenomics Market, by Region, Through 2029
Table 9 : Global Single-cell Genomics and Proteomics Market, by Application, Through 2029
Table 10 : Global Single-cell Genomics and Proteomics Market for Oncology, by Region, Through 2029
Table 11 : Global Single-cell Genomics and Proteomics Market for Stem Cell Biology, by Region, Through 2029
Table 12 : Global Single-cell Genomics and Proteomics Market for Immunology, by Region, Through 2029
Table 13 : Global Single-cell Genomics and Proteomics Market for Other Applications, by Region, Through 2029
Table 14 : Global Single-cell Genomics and Proteomics Market, by End User, Through 2029
Table 15 : Global Single-cell Genomics and Proteomics Market for Academic and Research Organizations, by Region, Through 2029
Table 16 : Global Single-cell Genomics and Proteomics Market for Biopharmaceutical and Biotechnology Companies, by Region, Through 2029
Table 17 : Global Single-cell Genomics and Proteomics Market for Clinical Laboratories, by Region, Through 2029
Table 18 : Global Single-cell Genomics and Proteomics Market for Applied Markets, by Region, Through 2029
Table 19 : Global Single-cell Genomics and Proteomics Market, by Region, Through 2029
Table 20 : North American Genomics and Proteomics Market, by Analysis Type, Through 2029
Table 21 : North American Genomics and Proteomics Market, by Application, Through 2029
Table 22 : North American Genomics and Proteomics Market, by End User, Through 2029
Table 23 : European Genomics and Proteomics Market, by Analysis Type, Through 2029
Table 24 : European Genomics and Proteomics Market, by Application, Through 2029
Table 25 : European Genomics and Proteomics Market, by End User, Through 2029
Table 26 : Asia-Pacific Genomics and Proteomics Market, by Analysis Type, Through 2029
Table 27 : Asia-Pacific Genomics and Proteomics Market, by Application, Through 2029
Table 28 : Asia-Pacific Genomics and Proteomics Market, by End User, Through 2029
Table 29 : RoW Genomics and Proteomics Market, by Analysis Type, Through 2029
Table 30 : RoW Genomics and Proteomics Market, by Application, Through 2029
Table 31 : RoW Genomics and Proteomics Market, by End User, Through 2029
Table 32 : Top Players in the Single-cell Genomics and Proteomics Market, 2023
Table 33 : Collaborations and Partnerships: Single-cell Genomics and Proteomics Market, 2021–2024
Table 34 : New Product Launch: Single-cell Genomics and Proteomics Market, 2021–2024
Table 35 : Expansions and Investments: Single-cell Genomics and Proteomics Market, 2021–2024
Table 36 : Mergers and Acquisitions: Single-cell Genomics and Proteomics Market, 2020–2024
Table 37 : Single-cell Genomics and Proteomics Market: Patent Analysis, 2018–2024
Table 38 : Key Focus Areas in ESG Metrics
Table 39 : Environmental Performance Initiatives in the Genomics and Proteomics Market
Table 40 : Social Performance Initiatives in the Genomics and Proteomics Market
Table 41 : Governance Performance Initiatives in the Genomics and Proteomics Market
Table 42 : ESG Rankings for Genomics and Proteomics Companies, 2024*
Table 43 : Abbreviations Used in this Report
Table 44 : 10x Genomics: Company Snapshot
Table 45 : 10x Genomics: Financial Performance, FY 2022 and 2023
Table 46 : 10x Genomics: Product Portfolio
Table 47 : 10x Genomics: News/Key Developments, 2024
Table 48 : Agilent Technologies Inc.: Company Snapshot
Table 49 : Agilent Technologies Inc.: Financial Performance, FY 2022 and 2023
Table 50 : Agilent Technologies Inc.: Product Portfolio
Table 51 : Agilent Technologies Inc.: News/Key Developments, 2023
Table 52 : BD: Company Snapshot
Table 53 : BD: Financial Performance, FY 2023 and 2024
Table 54 : BD: Product Portfolio
Table 55 : BD: News/Key Developments, 2023–2024
Table 56 : Bio-Rad Laboratories Inc.: Company Snapshot
Table 57 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2022 and 2023
Table 58 : Bio-Rad Laboratories Inc.: Product Portfolio
Table 59 : Bio-Rad Laboratories Inc.: News/Key Developments, 2024
Table 60 : Bio-Techne: Company Snapshot
Table 61 : Bio-Techne: Financial Performance, FY 2022 and 2023
Table 62 : Bio-Techne: Product Portfolio
Table 63 : Bio-Techne: News/Key Developments, 2022
Table 64 : Bruker: Company Snapshot
Table 65 : Bruker: Financial Performance, FY 2022 and 2023
Table 66 : Bruker: Product Portfolio
Table 67 : Bruker: News/Key Developments, 2024
Table 68 : F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 69 : F. Hoffman-La Roche Ltd.: Financial Performance, FY 2022 and 2023
Table 70 : F. Hoffman-La Roche Ltd.: Product Portfolio
Table 71 : F. Hoffman-La Roche Ltd.: News/Key Developments, 2021–2022
Table 72 : Illumina Inc.: Company Snapshot
Table 73 : Illumina Inc.: Financial Performance, FY 2022 and 2023
Table 74 : Illumina Inc.: Product Portfolio
Table 75 : Illumina Inc.: News/Key Developments, 2022–2023
Table 76 : Merck KGaA: Company Snapshot
Table 77 : Merck KGaA: Financial Performance, FY 2022 and 2023
Table 78 : Merck KGaA: Product Portfolio
Table 79 : Promega Corp.: Company Snapshot
Table 80 : Promega Corp.: Product Portfolio
Table 81 : Promega Corp.: News/Key Developments, 2022–2023
Table 82 : Qiagen: Company Snapshot
Table 83 : Qiagen: Financial Performance, FY 2022 and 2023
Table 84 : Qiagen: Product Portfolio
Table 85 : Qiagen: News/Key Developments, 2022–2024
Table 86 : Sartorius AG: Company Snapshot
Table 87 : Sartorius AG: Financial Performance, FY 2022 and 2023
Table 88 : Sartorius AG: Product Portfolio
Table 89 : Sartorius AG: News/Key Developments, 2024
Table 90 : Standard BioTools: Company Snapshot
Table 91 : Standard BioTools: Financial Performance, FY 2022 and 2023
Table 92 : Standard BioTools: Product Portfolio
Table 93 : Standard BioTools: News/Key Developments, 2022–2024
Table 94 : Tecan Trading AG: Company Snapshot
Table 95 : Tecan Trading AG: Financial Performance, FY 2022 and 2023
Table 96 : Tecan Trading AG: Product Portfolio
Table 97 : Tecan Trading AG: News/Key Developments, 2024
Table 98 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 99 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 100 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 101 : Thermo Fisher Scientific Inc.: News/Key Developments, 2022–2024
List of Figures
Summary Figure : Global Single-cell Genomics and Proteomics Market Share, by Region, 2023
Figure 1 : Types of Omics
Figure 2 : Porter’s Five Forces Analysis for the Single-cell Genomics and Proteomics Market
Figure 3 : Market Dynamics of Single-cell Genomics and Proteomics
Figure 4 : Global Single-cell Genomics and Proteomics Market Share, by Analysis Type, 2023
Figure 5 : Global Single-cell Genomics Market Share, by Region, 2023
Figure 6 : Global Single-cell Proteomics Market Share, by Region, 2023
Figure 7 : Global Single-cell Transcriptomics Market Share, by Region, 2023
Figure 8 : Global Single-cell Epigenomics Market Share, by Region, 2023
Figure 9 : Global Single-cell Genomics and Proteomics Market Share, by Application, 2023
Figure 10 : Global Single-cell Genomics and Proteomics Market Share, by End User, 2023
Figure 11 : Global Single-cell Genomics and Proteomics Market Share, by Region, 2023
Figure 12 : North American Single-cell Genomics and Proteomics Market Share, by Analysis Type, 2023
Figure 13 : European Single-cell Genomics and Proteomics Market Share, by Analysis Type, 2023
Figure 14 : Asia-Pacific Single-cell Genomics and Proteomics Market Share, by Analysis Type, 2023
Figure 15 : RoW Single-cell Genomics and Proteomics Market Share, by Analysis Type, 2023
Figure 16 : Snapshot of ESG Pillars
Figure 17 : Advantages of ESG for Companies
Figure 18 : Share of Biotech Companies Providing ESG Disclosure, 2022
Figure 19 : Share of ESG Disclosure Location for the Biotech Companies, 2022
Figure 20 : 10x Genomics: Revenue Share, by Business Unit, FY 2023
Figure 21 : 10x Genomics: Revenue Share, by Country/Region, FY 2023
Figure 22 : Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2023
Figure 23 : Agilent Technologies Inc.: Revenue Share, by Country/Region, FY 2023
Figure 24 : BD: Revenue Share, by Business Unit, FY 2024
Figure 25 : BD: Revenue Share, by Country/Region, FY 2024
Figure 26 : Bio-Rad Laboratories Inc.: Revenue Share, by Business Unit, FY 2023
Figure 27 : Bio-Rad Laboratories Inc.: Revenue Share, by Country/Region, FY 2023
Figure 28 : Bio-Techne: Revenue Share, by Business Unit, FY 2023
Figure 29 : Bio-Techne: Revenue Share, by Country/Region, FY 2023
Figure 30 : Bruker: Revenue Share, by Business Unit, FY 2023
Figure 31 : Bruker: Revenue Share, by Country/Region, FY 2023
Figure 32 : F. Hoffman-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 33 : F. Hoffman-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023
Figure 34 : Illumina Inc.: Revenue Share, by Business Unit, FY 2023
Figure 35 : Illumina Inc.: Revenue Share, by Country/Region, FY 2023
Figure 36 : Merck KGaA: Revenue Share, by Business Unit, FY 2023
Figure 37 : Merck KGaA: Revenue Share, by Country/Region, FY 2023
Figure 38 : Qiagen: Revenue Share, by Business Unit, FY 2023
Figure 39 : Qiagen: Revenue Share, by Country/Region, FY 2023
Figure 40 : Sartorius AG: Revenue Share, by Business Unit, FY 2023
Figure 41 : Sartorius AG: Revenue Share, by Country/Region, FY 2023
Figure 42 : Standard BioTools: Revenue Share, by Business Unit, FY 2023
Figure 43 : Standard BioTools: Revenue Share, by Country/Region, FY 2023
Figure 44 : Tecan Trading AG: Revenue Share, by Business Unit, FY 2023
Figure 45 : Tecan Trading AG: Revenue Share, by Country/Region, FY 2023
Figure 46 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2023
Figure 47 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2023
BCC Research（BCCリサーチ）はライフサイエンス、センサ、マテリアル、環境、商取引関連市場を中心とした広範な市場調査レポートを出版する米国の調査会社です。
ライセンス別価格表
2024年11月より価格構成が大幅に変更になりました。最新の価格についてはお問合せください。
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
新価格表
ライセンスタイプ1
| シングルユーザ | 2-5ユーザ | サイト | エンタープライズ |
| USD 4,650 | USD 5,580 | USD 6,696 | USD 8,035 |
ライセンスタイプ2
| シングルユーザ | 2-5ユーザ | サイト | エンタープライズ |
| USD 2,950 | USD 3,540 | USD 4,248 | USD 5,098 |
ライセンスタイプ3
| シングルユーザ | 2-5ユーザ | サイト | エンタープライズ |
| USD 2,500 | USD 3,000 | USD 3,600 | USD 4,320 |
旧価格表
旧ライセンスタイプ1
| シングルユーザ | 2-5ユーザ | サイト | エンタープライズ |
| USD 5,500 | USD 6,600 | USD7.920 | USD 9,504 |
旧ライセンスタイプ2
| シングルユーザ | 2-5ユーザ | サイト | エンタープライズ |
| USD 3,500 | USD 4,200 | USD 5,040 | USD 6,048 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- 2-5ライセンス
- 同一企業内5名までレポートファイルのご利用が可能です。
- サイトライセンス
- 同一企業同住所内でレポートファイルのご利用が可能です。
- エンタープライズライセンス
- 同一企業内人数無制限でレポートファイルのご利用が可能です。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- ご注文後3営業日以内
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
BCC Researchが出版する調査レポートのサンプルページのご依頼、見積り、ご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- がん免疫療法の技術と世界市場 2025-04-17
- 再生可能エネルギーの技術と世界市場 2025-04-17
- 木材・プラスチック複合材の技術と世界市場 2025-04-17
- 先端材料の調査レビュー 2024年 2025-04-16
- コールドチェーンの地域別市場分析：中東＆北アフリカ 2025-04-16
